4//SEC Filing
Brady James Aloysius 4
Accession 0001867096-25-000058
CIK 0001867096other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:45 PM ET
Size
4.9 KB
Accession
0001867096-25-000058
Insider Transaction Report
Form 4
Brady James Aloysius
Director
Transactions
- Award
Common Stock
2025-03-28+100,000→ 100,000 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001916987
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:45 PM ET
- Size
- 4.9 KB